Dealings in securities by a director and an associate of a director Mediclinic International Limited (Incorporated in the Republic of South Africa) (Registration number: 1983/010725/06) ISIN: ZAE000074142 JSE Share Code: MDC NSX Share Code: MCI ("Mediclinic" or “the Company”) DEALINGS IN SECURITIES BY A DIRECTOR AND AN ASSOCIATE OF A DIRECTOR In compliance with the Listings Requirements of the JSE Limited, the following information is disclosed: Director : Dr E de la H Hertzog (Chairman) Company : Mediclinic International Limited Date of transaction : 4 February 2016 Nature of transaction : Off market transfer of securities to a company of which Dr Hertzog is a director and shareholder. He will hold an indirect beneficial interest in the shares transferred. Class of securities : Ordinary shares Number of securities : 80 567 Selling price : R123.00 per share Total value of transaction : R9 909 741.00 Nature of interest : Direct beneficial Clearance obtained : Yes Director : Dr E de la H Hertzog (Chairman) Associate : Mrs E Hertzog (Wife) Company : Mediclinic International Limited Date of transaction : 4 February 2016 Nature of transaction : Off market transfer of securities by an associate of Dr Hertzog to a company of which Dr Hertzog is a director and shareholder. He will hold an indirect beneficial interest in the shares transferred. Class of securities : Ordinary shares Number of securities : 550 274 Selling price : R123.00 per share Total value of transaction : R67 683 702.00 Nature of interest : Dealings by an associate Clearance obtained : Yes Stellenbosch 5 February 2016 Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa PO Box 456, Stellenbosch 7599, South Africa Tel +27 (0)21 809 6500 Fax +27 (0)21 886 4037 Ethics Line: 0800 005 316 Website: www.mediclinic.com Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 05/02/2016 11:53:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.